1. Coronavirus Vaccine Tracker;Zimmer,2020
2. Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study|Moderna, Inchttps://investors.modernatx.com/news-releases/news-release-details/modernas-covid-19-vaccine-candidate-meets-its-primary-efficacy/
3. Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints|BioNTechhttps://investors.biontech.de/news-releases/news-release-details/pfizer-and-biontech-conclude-phase-3-study-covid-19-vaccine/
4. Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives
5. Tools for translation: non-viral materials for therapeutic mRNA delivery